Abstract
Trazodone is approved by the Food and Drug Administration (FDA) for the treatment of depression and anxiety in humans, it can perform these functions due to its selective serotonin receptor antagonism and reuptake inhibition properties. Trazodone has not been approved for animals by the FDA but it is legally prescribed by veterinarians as an off-label drug for dogs and cats. This review describes trazodone’s mechanism of action, pharmacokinetic properties and adverse effects and summarizes the benefits of trazodone for non-approved FDA indications to reduce anxiety, behavioral stress, sedation, pre-and post-operation stress. It also discusses its cardiac safety profile for dogs and cats. As few clinical trials have been conducted to evaluate trazodone’s efficacy for treatment of the many behavioral and medical conditions in animals, large and randomized controlled clinical trials are still needed to confirm its efficacy in clinical practice.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: American Journal of Animal and Veterinary Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
